Pharmacyclics, Inc. News Headlines

Get PCYC Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PCYC After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By
Stocks Under Pressure Amid Global Economic Concerns - U.S. Commentary
10/7/2014 10:25:00 AM - RTT News

Individual Investor Portfolio: Major Sectors Are Beginning To Move In Opposing Directions
10/4/2014 3:39:00 AM - Seeking Alpha

Gilead Sciences, Inc. Stock's Stunning New Opportunity
9/30/2014 8:15:02 AM - Motley Fool

FDA Decision On Imbruvica Will Push Pharmacyclics Higher
9/29/2014 1:32:00 PM - Seeking Alpha

Cramer's Lightning Round - People Need H&R Block More Than Ever (9/17/14)
9/18/2014 4:53:00 AM - Seeking Alpha

Modest Weakness Remains Visible On Wall Street - U.S. Commentary
9/11/2014 12:04:00 PM - RTT News

Stocks Remain Nearly Flat In Mid-Day Trading - U.S. Commentary
9/10/2014 12:16:00 PM - RTT News

Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News
9/3/2014 5:47:20 PM - Zacks.com

Gilead: Rising Short Interest Provides Yet Another Reason To Own The Stock
8/15/2014 2:40:00 PM - Seeking Alpha

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/13/2014 2:06:00 AM - Zacks.com

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/12/2014 2:06:00 PM - Investopedia

Patient Bulls Finally Get A New Entry Point, Thanks To Inflation Fears
8/4/2014 4:45:00 PM - Seeking Alpha

Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
8/1/2014 4:10:00 PM - Zacks.com

Pharmacyclics (PCYC) Jumps: Stock Rises 15% - Tale of the Tape
7/30/2014 8:39:00 AM - Zacks.com

Stock Pickers Rule - Investment Ideas
7/30/2014 2:51:00 AM - Zacks.com

PCYC Makes Bullish Cross Above Critical Moving Average
7/29/2014 10:49:49 AM - BNK Invest

Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
7/28/2014 4:15:00 PM - Zacks.com

Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
7/21/2014 2:06:00 PM - Seeking Alpha

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
7/8/2014 8:01:00 AM - Seeking Alpha

Individual Investor Portfolio Update: Diversifying For Growth
7/1/2014 1:40:00 AM - Seeking Alpha

Cramer's Mad Money - 9 Things To Watch In The Week Ahead (6/20/14)
6/22/2014 5:10:00 AM - Seeking Alpha

Fire Up The Immuno-Oncology Powerhouses: John McCamant
6/19/2014 5:39:00 PM - Seeking Alpha

Pharmacyclics' Imbruvica Under FDA Priority Review - Analyst Blog
6/10/2014 5:45:00 PM - Zacks.com

Encouraging Data on Pharmacyclics/J&J Drug - Analyst Blog
6/2/2014 11:10:00 AM - Zacks.com